Form 4: Butcher Arthur C reports multiple insider transactions in BSX

Rhea-AI Filing Summary

Butcher Arthur C reported multiple insider transaction types in a Form 4 filing for BSX. The filing lists transactions totaling 57,681 shares at a weighted average price of $74.12 per share. Following the reported transactions, holdings were 5,386 shares.

Insights

Equity Compensation Analyst

Routine stock awards and option grants to a senior executive, with tax withholding on shares.

Arthur C. Butcher, an executive at Boston Scientific, reported standard equity compensation activity. He exercised 2,692 restricted stock units into common shares and had 1,302 shares withheld to satisfy tax liabilities, a common practice that does not represent an open-market sale.

He was granted 15,178 new restricted stock units and stock options on 35,817 shares, expanding his long-term, performance-linked exposure to the company. These awards vest in equal annual installments starting on February 12, 2027, aligning incentives over multiple years.

After the transactions, he held 24,990 common shares directly and 13,354 indirectly via a 401(k) plan, plus unvested restricted stock units and options. Taken together, these moves look like routine compensation rather than a directional bet on the stock.

Insider Trade Summary

2,692 shares exercised/converted

Mixed 6 txns

Insider Butcher Arthur C

Role EVP& Grp Pres, MedSurg & APAC

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	2,692	$0.00	--
Grant/Award	Restricted Stock Units	15,178	$0.00	--
Grant/Award	Stock Option (Right to Buy)	35,817	$0.00	--
Exercise	Common Stock	2,692	$0.00	--
Tax Withholding	Common Stock	1,302	$74.12	$97K
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 5,386 shares (Direct); Stock Option (Right to Buy) — 35,817 shares (Direct); Common Stock — 26,292 shares (Direct); Common Stock — 13,354 shares (Indirect, By 401(k))

Footnotes (1)

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Butcher Arthur C

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MA 01752-1234

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP& Grp Pres, MedSurg & APAC

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/12/2026		M		2,692	A	$0.0000(1)	26,292	D
Common Stock	02/12/2026		F		1,302	D	$74.12	24,990	D
Common Stock								13,354(2)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/12/2026		M			2,692	(3)	02/12/2028(3)	Common Stock	2,692	$0.0000	5,386	D
Restricted Stock Units	(1)	02/12/2026		A		15,178		(4)	02/12/2030(4)	Common Stock	15,178	$0.0000	15,178	D
Stock Option (Right to Buy)	$74.12	02/12/2026		A		35,817		(5)	02/12/2036	Common Stock	35,817	$0.0000	35,817	D

Explanation of Responses:

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.

4. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

5. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

	/s/ Susan Thompson, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did BSX executive Arthur C. Butcher report on February 12, 2026?

Arthur C. Butcher exercised 2,692 restricted stock units into common shares and had 1,302 shares withheld for taxes. He also received 15,178 new restricted stock units and stock options on 35,817 shares, all reported as direct beneficial ownership changes.

Did Arthur C. Butcher sell Boston Scientific (BSX) shares in the open market?

The filing shows no open-market sale. Instead, 1,302 shares of Boston Scientific common stock were disposed of at $74.12 per share as a tax-withholding transaction to cover obligations from an equity award, which differs from a discretionary share sale.

How many Boston Scientific shares does Arthur C. Butcher own after these Form 4 transactions?

After the reported transactions, Arthur C. Butcher directly owned 24,990 shares of Boston Scientific common stock and indirectly held 13,354 shares through a 401(k) plan, in addition to his restricted stock units and stock options reported as derivative securities.

What new equity awards did Boston Scientific grant to Arthur C. Butcher?

He received 15,178 restricted stock units and stock options covering 35,817 shares of Boston Scientific common stock. These awards carry future vesting schedules in four equal annual installments, tying a portion of his compensation to the company’s long-term performance.

How do Arthur C. Butcher’s restricted stock units in BSX convert into common stock?

Each restricted stock unit represents a commitment by Boston Scientific to issue one share of common stock. Previously granted units are scheduled to convert into shares in four equal annual installments beginning on specific grant anniversaries, as detailed in the Form 4 footnotes.

What are the vesting terms of Arthur C. Butcher’s new Boston Scientific stock options?

The new stock options on 35,817 Boston Scientific shares vest in four equal annual installments beginning on February 12, 2027. This schedule, described in the footnotes, is designed to retain the executive and align his incentives with shareholders over several years.